| Trial ID: | L0511 |
| Source ID: | NCT00625820
|
| Associated Drug: |
6r Bh4
|
| Title: |
Tetrahydrobiopterin in Patients With Chronic Kidney Disease (CKD) and Albuminuria
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00625820/results
|
| Conditions: |
Kidney Disease|Albuminuria
|
| Interventions: |
DRUG: 6R BH4|DIETARY_SUPPLEMENT: Vitamin C
|
| Outcome Measures: |
Primary: The Primary Outcome Measure is Level of Albuminuria., Early morning urine specimens were collected to calculate albumin and creatinine ratio (albuminuria) at 6 and 12 weeks of therapy., 12 weeks | Secondary: Systolic Blood Pressure Measured at 6 and 12 Weeks of Therapy., 12 weeks|Estimated Glomerular Filtration Rate (eGFR) Measured at 6 and 12 Weeks of Therapy., 12 weeks
|
| Sponsor/Collaborators: |
Sponsor: University of Michigan | Collaborators: BioMarin Pharmaceutical
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
17
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2008-05
|
| Completion Date: |
2008-09
|
| Results First Posted: |
2016-10-18
|
| Last Update Posted: |
2016-10-18
|
| Locations: |
University of Michigan, Ann Arbor, Michigan, 48109, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00625820
|
